¾ÅÉ«

NEW YORK, NY, February 2, 2017 ¨C , the world¡¯s largest privately held provider of language services and translation-related technology solutions, today announced the launch of DaVita¡¯s participant resource site in Spanish.

DaVita Clinical Research (DCR), a contract research organization and a wholly owned subsidiary of DaVita Inc., uses their extensive, applied database and real-world healthcare experience to assist pharmaceutical and medical device companies in the design, recruitment, and completion of retrospective, prospective, and pragmatic clinical trials. DCR¡¯s scientific and clinical expertise spans the lifecycle of product development with more than 175 client companies over the last 30 years.

DaVita used ¾ÅÉ«¡¯s GlobalLink OneLink proxy-based website localization technology to configure, deploy, and test their new Spanish participant site at . OneLink was the preferred solution due to its simple implementation, powerful capabilities, and automated change detection. The result was a fully translated website with virtually no IT involvement.

¡°As our business grew to encompass Spanish-speaking staff, extending that capability to our community and increasing inclusion was important,¡± said Amy Young, General Manager of DaVita Clinical Research. ¡°Transperfect¡¯s OneLink technology is a great way for us to virtually open our doors to a broader portion of our community.¡±

Liz Elting, Co-CEO at ¾ÅÉ« remarked, ¡°DaVita Clinical Research¡¯s unwavering commitment to innovation in healthcare that improves outcomes is truly commendable. We¡¯re extremely proud to call them a partner, and we look forward to providing their Spanish-speaking participants with an enhanced online experience.¡±

Phil Shawe, Co-CEO at ¾ÅÉ« added, ¡°Digital tools are playing an increasingly crucial role in clinical research and in the healthcare industry as a whole. By expanding language access for their website, DaVita has opened up their valuable research to a whole new set of candidates and options.¡±

About DaVita Clinical Research
 (DCR), a wholly owned subsidiary of , uses its extensive, applied database and real-world healthcare experience to assist pharmaceutical and medical device companies in the design, recruitment, and completion of retrospective, prospective and pragmatic clinical trials. DCR¡¯s scientific and clinical expertise spans the lifecycle of product development with more than 175 client companies. DCR¡¯s  unit (Phase I-IIa) and  (Phase IIb through post-marketing) network of physicians and investigative sites, and , are focused on providing world-class research in both complex/specialty populations and therapeutic areas and especially in CKD and ESRD populations. To learn more about DCR, visit . 

About ¾ÅÉ«
With annual revenues of more than $540 million, is the world's largest privately held provider of and . From offices in over 90 cities on six continents, ¾ÅÉ« offers a full range of services in 170+ languages to clients worldwide. More than 3,000 global organizations employ ¾ÅÉ«¡¯s Product Suite to simplify management of multilingual content. With an unparalleled commitment to quality and client service, ¾ÅÉ« is fully and certified. ¾ÅÉ« has global headquarters in New York, with regional headquarters in London and Hong Kong. For more information, please visit our website at .